Latest AI and machine learning research in oncology/hematology for healthcare professionals.
The purpose of the study is to determine if artificial intelligence (AI) models could provide dietar...
BACKGROUND: Artificial intelligence (AI)-based imaging analysis and circulating tumor-associated DNA...
PURPOSE: Endometrial cancer (EC) is the most common gynecologic cancer in the United States with ris...
Lung cancer has been stated as one of the prevalent killers of cancer up to this present time and th...
Prostate cancer (PCa) requires improved diagnostic strategies beyond conventional imaging. This revi...
BACKGROUND: Patients with early-stage non-small cell lung cancer (NSCLC) typically receive surgery a...
BACKGROUND: Advancements in diagnostic and therapeutic modalities for giant cell tumors of bone (GCT...
Post-hepatectomy liver failure (PHLF) is a severe complication following liver surgery. We aimed to ...
OBJECTIVES: Superficial esophageal squamous cell carcinoma (ESCC) detection is crucial. Although nar...
Dipeptidyl peptidase-IV (DPP-IV) is a circulating blood biomarker that diagnose pancreatic and thyro...
Per- and polyfluoroalkyl substances (PFAS) are persistent environmental contaminants with widespread...
Cancer remains one of the leading causes of mortality worldwide, making early diagnosis and precise ...
BACKGROUND AND OBJECTIVES: Prostate cancer is the most common form of cancer in the male population....
Patients with cardioembolic stroke often undergo CT of the left atrial appendage (LAA), for example,...
Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous variant of breast cancer dis...
This project aimed to develop and evaluate an automated, AI-based, volumetric brain tumor MRI respon...
BACKGROUND: To develop a deep learning radiomics (DLR) model based on contrast-enhanced computed tom...
Building deep learning models that can rapidly segment whole slide images (WSIs) using only a handfu...
BACKGROUND: Artificial intelligence (AI) is increasingly being explored for its potential role in me...
PURPOSE: Recurrent glioblastoma has a poor prognosis, and its optimal management remains unclear. Re...
There is no standard of care in relapsed/refractory T-cell/natural killer-cell lymphomas. Patients o...